Praxis Precision Medicines (PRAX) EBIT Growth (3y) (2022 - 2026)

Praxis Precision Medicines (PRAX) EBIT Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 38.78%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 13.47%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -12.10%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 79.65%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Praxis Precision Medicines 9.37 Bn 8.58 Bn - -40.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 -40.59%
Dec 31, 2025 -32.78%
Sep 30, 2025 -20.95%
Jun 30, 2025 -7.99%
Mar 31, 2025 -2.77%
Dec 31, 2024 -2.92%
Sep 30, 2024 -8.28%
Jun 30, 2024 -0.91%
Mar 31, 2024 -15.17%
Dec 31, 2023 -2.64%
Sep 30, 2023 -16.31%
Jun 30, 2023 -44.57%
Mar 31, 2023 -65.07%
Dec 31, 2022 -76.85%
Sep 30, 2022 -60.79%